Company / PP&E per Share
Cytek Biosciences, Inc. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.14
FY2025
5-year range
$0.10 / $0.19
FY2021-FY2025
Trend
+0.8%
vs FY2024
Sector context
#117 of 130
Health Care
What the data says
Among 130 Health Care companies, Cytek Biosciences, Inc. is in the bottom 10% for pp&e per share. PP&E per Share has fluctuated over the past 6 years, ranging from $0.07 in FY2020 to $0.19 in FY2021.
Based on SEC 10-K filings.
0.14 in FY2025 with a 5-year CAGR of +16.4%.
Remained stable around $0.14 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- +16.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 130This company $0.14 Sector average $11.80
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 0.8% year-over-year.
- Ranks #117 out of 130 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2021.
- Lowest pp&e per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | +0.8% |
| FY2024 | $0.14 | -1.3% |
| FY2023 | $0.14 | +37.6% |
| FY2022 | $0.10 | -45.4% |
| FY2021 | $0.19 | +185.3% |
| FY2020 | $0.07 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026